BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 153766)

  • 1. Modification of high molecular weight plasmic degradation products of human crosslinked fibrin.
    Olexa SA; Budzynski AZ; Marder VJ
    Biochim Biophys Acta; 1979 Jan; 576(1):39-50. PubMed ID: 153766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary soluble plasmic degradation product of human cross-linked fibrin. Isolation and stoichiometry of the (DD)E complex.
    Olexa SA; Budzynski AZ
    Biochemistry; 1979 Mar; 18(6):991-5. PubMed ID: 154923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.
    Francis CW; Marder VJ; Barlow GH
    J Clin Invest; 1980 Nov; 66(5):1033-43. PubMed ID: 6448866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interference of plasmic degradation products of human crosslinked fibrin with clot formation.
    Budzynski AZ; Olexa SA; Brizuela BS
    Biochim Biophys Acta; 1979 May; 584(2):284-7. PubMed ID: 35237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    J Biol Chem; 1979 Jun; 254(11):4925-32. PubMed ID: 155698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes.
    Francis CW; Marder VJ; Martin SE
    Blood; 1980 Sep; 56(3):456-64. PubMed ID: 6447526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmic degradation of human fibrinogen. III. Molecular model of the plasmin-resistant disulfide knot in monomeric fragment D.
    Furlan M; Kemp G; Beck EA
    Biochim Biophys Acta; 1975 Jul; 400(1):95-111. PubMed ID: 125109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
    Ferguson EW; Fretto LJ; McKee PA
    J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
    Marder VJ; Budzynski AZ; Barlow GH
    Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular model of plasmic degradation of crosslinked fibrin.
    Francis CW; Marder VJ
    Semin Thromb Hemost; 1982 Jan; 8(1):25-35. PubMed ID: 6460319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmic degradation of human fibrinogen. IV. Identification of subunit chain remnants in fragment Y.
    Furlan M; Seelich T; Beck EA
    Biochim Biophys Acta; 1975 Jul; 400(1):112-20. PubMed ID: 125108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin.
    Gaffney PJ; Lane DA; Brasher M
    Clin Sci Mol Med; 1975 Aug; 49(2):149-56. PubMed ID: 125178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmic degradation of bovine fibrinogen and non-crosslinked fibrins in solution and in gel form.
    Inoue N; Moroi M; Yamasaki M
    Biochim Biophys Acta; 1975 Aug; 400(2):322-33. PubMed ID: 240417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma crosslinked fibrin polymers: quantitation based on tissue plasminogen activator conversion to D-dimer and measurement in normal and patients with acute thrombotic disorders.
    Kornberg A; Francis CW; Marder VJ
    Blood; 1992 Aug; 80(3):709-17. PubMed ID: 1386260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex-formation between the fibrin-derived plasmic fragments DD and E demonstrated by crossed immunoelectrophoresis.
    Gogstad GO; Brosstad F
    Thromb Res; 1983 Jun; 30(5):441-8. PubMed ID: 6225217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
    Krajewski T; Nowak P; Cierniewski C
    Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
    Cierniewski CS; Kloczewiak M; Budzynski AZ
    J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.